By Dr Lindsay Edward Wu

Patents

Wu L; Sinclair D, 2022, Targeting NAD+ to treat chemotherapy and radiotherapy induced cognitive impairment, neuropathies and inactivity, Patent No. Belgium, Denmark, Europe, France, Germany, Ireland, Italy, Netherlands, Poland, Portugal, Spain, Sweden, Switzerland, United Kingdom - 3288637; Japan - 7193232; United States - 11389469

Wu L; Sinclair D, 2020, Targeting NAD+ to treat chemotherapy and radiotherapy induced cognitive impairment, neuropathies and inactivity, Patent No. United Stated Patent no. 10603334

Sinclair D; Gomes A; Wu L, 2018, NAD biosynthesis and precursors for the treatment and prevention of cancer and proliferation, Patent No. 9877981, https://pdfpiw.uspto.gov/.piw?Docid=09877981&homeurl=http:%2F%2Fpatft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO1%2526Sect2%3DHITOFF%2526d%3DPALL%2526p%3D1%2526u%3D%25252Fnetahtml%25252FPTO%25252Fsrchnum.htm%2526r%3D1%2526f%3DG%2526l%3D50%2526s1%3D9877981.PN.%2526OS%3DPN%2F9877981%2526RS%3DPN%2F9877981&PageNum=&Rtype=&SectionNum=&idkey=NONE&Input=View+first+page

Back to profile page